Latest / Decera Clinical Education Oncology Podcast
Congress to Clinic: Expert Takeaways on Emerging Data for AML
In this episode, listen to Professor Eunice S. Wang, MD, share her clinical insights and takeaways on new data for acute myeloid leukemia (AML) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including:
Data from the prospective, single-center phase Ib/II study of FLAG-IDA plus venetoclax in newly diagnosed or relapsed/refractory AML
Phase I/II study of oral decitabine/cedazuridine with venetoclax and gilteritinib in patients with newly diagnosed and relapsed/refractory FLT3-mutant AML
A retrospective comparison of abbreviated course 7+7 vs standard HMA plus venetoclax…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.